SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015533
Filing Date
2022-08-08
Accepted
2022-08-08 16:12:57
Documents
63
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dsgn-20220630.htm   iXBRL 10-Q 2803721
2 EX-31.1 dsgn-ex31_1.htm EX-31.1 21418
3 EX-32.1 dsgn-ex32_1.htm EX-32.1 15079
  Complete submission text file 0000950170-22-015533.txt   8391528

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dsgn-20220630_pre.xml EX-101.PRE 255944
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dsgn-20220630_lab.xml EX-101.LAB 355590
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dsgn-20220630.xsd EX-101.SCH 45181
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dsgn-20220630_def.xml EX-101.DEF 135984
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dsgn-20220630_cal.xml EX-101.CAL 40489
57 EXTRACTED XBRL INSTANCE DOCUMENT dsgn-20220630_htm.xml XML 1575711
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40288 | Film No.: 221144511
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences